Additive Selection for Nitrosation Suppression in Pharmaceutical Formulations
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods are inadequate for effectively suppressing nitrosation reactions in pharmaceutical compositions, as eliminating amines or blocking NOx sources is impractical, and antioxidants can degrade active ingredients or alter their profiles.
Innovation Solution
A method for selecting an additive agent by generating nitroso compounds under controlled conditions, quantifying their amount, and evaluating their suppressing effect, using amine and NOx sources, with specific additives like sodium stearyl fumarate and magnesium oxide to reduce nitroso compound generation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-generated harmful factors
If antioxidants are used to suppress nitrosation reactions, then nitroso compound generation is reduced, but active ingredient degradation increases
Solution Approach 1:
The patent introduces a new class of additives (sulfur-containing compounds, phosphorus-containing compounds, or their combinations) as intermediary substances that specifically suppress nitrosation reactions without the harmful side effects of antioxidants. These compounds act as mediators between the amine source and NOx source, preventing nitroso compound formation through alternative chemical pathways that do not involve oxidative degradation of the active ingredient.
Solution Approach 2:
The patent changes the chemical parameter of the additive agent from traditional antioxidants to sulfur-containing or phosphorus-containing compounds. This parameter change fundamentally alters the mechanism of nitrosation suppression, shifting from oxidation-based inhibition to a different chemical pathway that is selective for nitrosation reactions only, thereby preserving active ingredient integrity.
2Object-generated harmful factors
If amines are eliminated from the formulation, then nitroso compound generation is reduced, but pharmaceutical composition functionality deteriorates
Solution Approach 1:
The sulfur-containing or phosphorus-containing compounds serve as intermediary substances that allow the presence of amines in the formulation while preventing their conversion to nitroso compounds. These mediators create a protective chemical environment where amines can fulfill their pharmaceutical functions without undergoing harmful nitrosation reactions.
Solution Approach 2:
The patent extracts the harmful nitrosation reaction pathway from the system by introducing substances that specifically intercept the nitrosation mechanism, while leaving the amine-containing active ingredients and their necessary functions intact. This selective removal of the harmful pathway preserves the beneficial amine functionality.
3Object-generated harmful factors
If NOx sources are blocked in the formulation, then nitroso compound generation is reduced, but manufacturing process complexity increases
Solution Approach 1:
Instead of blocking NOx sources through complex manufacturing controls, the patent introduces sulfur-containing or phosphorus-containing compounds as intermediaries that naturally suppress nitrosation reactions under normal manufacturing conditions. This approach eliminates the need for complex NOx source blocking mechanisms while achieving the same protective effect.
Solution Approach 2:
The additive agents (sulfur-containing or phosphorus-containing compounds) provide self-service by automatically suppressing nitrosation reactions whenever amine sources and NOx sources are present in the formulation, without requiring external control mechanisms or complex manufacturing processes to block NOx sources.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method allows for the selection of additive agents that suppress nitrosation reactions, keeping nitroso compound levels below acceptable limits while maintaining pharmaceutical composition quality.
Implementation Method 1
nitrosation (addition of a nitroso group on the amine nitrogen) of amines by a NOx source such as nitrous acid
Data Source
Figure 1
Figure 2
Figure 3
AI summary
One embodiment according to this invention provides a method for selecting an additive agent for suppressing a nitrosation reaction. Alternatively, one embodiment of the present invention provides a formulation that suppresses the generation of nitroso compounds, including an additive agent selected by a method for selecting an additive agent for suppressing a nitrosation reaction. In one embodiment, a method for selecting an additive agent for suppressing a nitrosation reaction includes adding an amine source and an NOx source to an additive agent to generate nitroso compounds, quantifying an amount of the generated nitroso compounds, and evaluating a suppressing effect of the nitrosation reaction of the additive agent based on the amount of the generated nitroso compounds.